{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:57:30Z","timestamp":1783040250235,"version":"3.54.6"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jtha.2025.11.021","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T07:15:35Z","timestamp":1765782935000},"page":"817-836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Treatment of acute pulmonary embolism: a comparison of international guideline recommendations"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0389-5386","authenticated-orcid":false,"given":"Casper","family":"Falster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gro","family":"Egholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jess","family":"Lambrechtsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9102-3130","authenticated-orcid":false,"given":"Asger","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Agerbo","family":"Gaist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert","family":"Bauersach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9961-0754","authenticated-orcid":false,"given":"Frederikus A.","family":"Klok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4057-758X","authenticated-orcid":false,"given":"Anton","family":"Vonk-Noordegraaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.11.021_bib1","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","article-title":"Global burden of thrombosis: epidemiologic aspects","volume":"118","author":"Wendelboe","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jtha.2025.11.021_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.28","article-title":"Pulmonary embolism","volume":"4","author":"Huisman","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jtha.2025.11.021_bib3","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1055\/a-2031-3859","article-title":"Contemporary management and clinical course of acute pulmonary embolism: the COPE study","volume":"123","author":"Becattini","year":"2023","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.021_bib4","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic therapy for VTE Disease: second update of the CHEST Guideline and Expert Panel Report","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2025.11.021_bib5","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.annemergmed.2018.03.006","article-title":"Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with suspected acute venous thromboembolic disease","volume":"71","author":"Wolf","year":"2018","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jtha.2025.11.021_bib6","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/CIR.0b013e318214914f","article-title":"Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association","volume":"123","author":"Jaff","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2025.11.021_bib7","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.11.021_bib8","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2018-211539","article-title":"British Thoracic Society Guideline for the initial outpatient management of pulmonary embolism (PE)","volume":"73","author":"Howard","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.jtha.2025.11.021_bib9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2025.11.021_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1024\/0301-1526\/a001089","article-title":"Diagnostics and therapy of venous thrombosis and pulmonary embolism","volume":"52","author":"Linnemann","year":"2023","journal-title":"Vasa"},{"key":"10.1016\/j.jtha.2025.11.021_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.23736\/S0392-9590.23.05177-5","article-title":"Prevention and management of venous thromboembolism. International consensus statement. Guidelines according to scientific evidence","volume":"43","author":"Nicolaides","year":"2024","journal-title":"Int Angiol"},{"key":"10.1016\/j.jtha.2025.11.021_bib12","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1253\/circj.CJ-88-0010","article-title":"Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2009)","volume":"75","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.jtha.2025.11.021_bib14","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619853037","article-title":"Diagnosis, treatment and follow up of acute pulmonary embolism: consensus practice from the PERT Consortium","volume":"25","author":"Rivera-Lebron","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2025.11.021_bib15","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.arbres.2013.07.008","volume":"49","author":"Uresandi","year":"2013","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.jtha.2025.11.021_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.5694\/mja2.50004","article-title":"New guidelines from the Thrombosis and Haemostasis Society of Australia and New Zealand for the diagnosis and management of venous thromboembolism","volume":"210","author":"Tran","year":"2019","journal-title":"Med J Aust"},{"key":"10.1016\/j.jtha.2025.11.021_bib17","author":"S Weinberg"},{"key":"10.1016\/j.jtha.2025.11.021_bib18","doi-asserted-by":"crossref","first-page":"e922","DOI":"10.1016\/S2352-3026(23)00181-3","article-title":"Comparison of international guideline recommendations for the diagnosis of pulmonary embolism","volume":"10","author":"Falster","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtha.2025.11.021_bib19","first-page":"129","article-title":"Pulmonary embolism, part I: epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism","volume":"18","author":"B\u0115lohl\u00e1vek","year":"2013","journal-title":"Exp Clin Cardiol"},{"key":"10.1016\/j.jtha.2025.11.021_bib20","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/CIRCULATIONAHA.107.726232","article-title":"Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry","volume":"117","author":"Laporte","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2025.11.021_bib21","doi-asserted-by":"crossref","first-page":"00641","DOI":"10.1183\/23120541.00641-2022","article-title":"Prognostic role of different findings at echocardiography in acute pulmonary embolism: a critical review and meta-analysis","volume":"9","author":"Cimini","year":"2023","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jtha.2025.11.021_bib22","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.amjmed.2015.01.023","article-title":"Predictive value of computed tomography in acute pulmonary embolism: systematic review and meta-analysis","volume":"128","author":"Meinel","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.jtha.2025.11.021_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.rmed.2019.08.011","article-title":"Elevated serum cardiac troponin and mortality in acute pulmonary embolism: systematic review and meta-analysis","volume":"157","author":"El-Menyar","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.jtha.2025.11.021_bib24","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa1302097","article-title":"Fibrinolysis for patients with intermediate-risk pulmonary embolism","volume":"370","author":"Meyer","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.11.021_bib25","first-page":"2933","article-title":"Safety of treating acute pulmonary embolism at home: an individual patient data meta-analysis","volume":"45","author":"Luijten","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2025.11.021_bib26","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1093\/eurheartj\/ehab373","article-title":"Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial","volume":"42","author":"Roy","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2025.11.021_bib27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/eurheartj\/ehz367","article-title":"Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial","volume":"41","author":"Barco","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2025.11.021_bib28","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1164\/rccm.200506-862OC","article-title":"Derivation and validation of a prognostic model for pulmonary embolism","volume":"172","author":"Aujesky","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jtha.2025.11.021_bib29","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1160\/TH08-05-0285","article-title":"Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism","volume":"100","author":"Donz\u00e9","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.021_bib30","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/archinternmed.2010.199","article-title":"Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism","volume":"170","author":"Jim\u00e9nez","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jtha.2025.11.021_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010324","article-title":"Prognostic models in acute pulmonary embolism: a systematic review and meta-analysis","volume":"6","author":"Elias","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.jtha.2025.11.021_bib32","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1538-7836.2011.04388.x","article-title":"Outpatient treatment in patients with acute pulmonary embolism: the Hestia study","volume":"9","author":"Zondag","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.021_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12959-016-0081-5","article-title":"External validation of prognostic rules for early post-pulmonary embolism mortality: assessment of a claims-based and three clinical-based approaches","volume":"14","author":"Weeda","year":"2016","journal-title":"Thromb J"},{"key":"10.1016\/j.jtha.2025.11.021_bib34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1378\/chest.15-0808","article-title":"Risk stratification of patients with acute symptomatic pulmonary embolism based on presence or absence of lower extremity DVT: systematic review and meta-analysis","volume":"149","author":"Becattini","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2025.11.021_bib35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2141.2005.05444.x","article-title":"Molecular mechanisms of fibrinolysis","volume":"129","author":"Cesarman-Maus","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.11.021_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/ph9030038","article-title":"Heparin: past, present, and future","volume":"9","author":"Oduah","year":"2016","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jtha.2025.11.021_bib37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000343108","article-title":"The discovery of vitamin K and its clinical applications","volume":"61","author":"Ferland","year":"2012","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.jtha.2025.11.021_bib38","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"EINSTEIN\u2013PE Investigators","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.11.021_bib39","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1302507","article-title":"Oral apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.11.021_bib40","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","article-title":"Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism","volume":"369","author":"Hokusai-VTE Investigators","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.11.021_bib41","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/CIRCULATIONAHA.113.004450","article-title":"Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis","volume":"129","author":"Schulman","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2025.11.021_bib42","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1182\/bloodadvances.2019000572","article-title":"Systematic review and meta-analysis of the efficacy and safety of apixaban compared to rivaroxaban in acute VTE in the real world","volume":"3","author":"Aryal","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.11.021_bib43","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/jamainternmed.2025.1109","article-title":"Oral anticoagulation and risk of adverse clinical outcomes in venous thromboembolism","volume":"185","author":"Bea","year":"2025","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jtha.2025.11.021_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2025.106438","article-title":"Bleeding risk on rivaroxaban versus apixaban in older patients with venous thromboembolism: a nationwide observational register-based study","volume":"142","author":"Roupe","year":"2025","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jtha.2025.11.021_bib47","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1111\/jth.15776","article-title":"Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease","volume":"20","author":"den Exter","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.021_bib48","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/eurheartj\/ehu218","article-title":"Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis","volume":"36","author":"Marti","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2025.11.021_bib49","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMoa021274","article-title":"Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism","volume":"347","author":"Konstantinides","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.11.021_bib50","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF01062714","article-title":"Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial","volume":"2","author":"Jerjes-Sanchez","year":"1995","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2025.11.021_bib51","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.jcin.2015.04.020","article-title":"A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II study","volume":"8","author":"Piazza","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jtha.2025.11.021_bib52","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.123.013406","article-title":"Outcomes in high-risk pulmonary embolism patients undergoing FlowTriever mechanical thrombectomy or other contemporary therapies: results from the FLAME study","volume":"16","author":"Silver","year":"2023","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jtha.2025.11.021_bib53","article-title":"Incidence of mortality and complications in high-risk pulmonary embolism: a systematic review and meta-analysis","volume":"2","author":"Silver","year":"2023","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"10.1016\/j.jtha.2025.11.021_bib56","article-title":"PEERLESS II: a randomized controlled trial of large-bore thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism","volume":"3","author":"Giri","year":"2024","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"10.1016\/j.jtha.2025.11.021_bib58","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ahj.2022.05.011","article-title":"Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: rationale and design of the HI-PEITHO study","volume":"251","author":"Klok","year":"2022","journal-title":"Am Heart J"},{"key":"10.1016\/j.jtha.2025.11.021_bib61","doi-asserted-by":"crossref","first-page":"e628","DOI":"10.1161\/CIR.0000000000001117","article-title":"Surgical management and mechanical circulatory support in high-risk pulmonary embolisms: historical context, current status, and future directions: a scientific statement from the American Heart Association","volume":"147","author":"Goldberg","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2025.11.021_bib62","first-page":"214","article-title":"A new look at pulmonary embolectomy","volume":"107","author":"Steenburg","year":"1958","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.jtha.2025.11.021_bib63","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jacc.2020.06.065","article-title":"Survival and right ventricular function after surgical management of acute pulmonary embolism","volume":"76","author":"Goldberg","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2025.11.021_bib64","first-page":"CD006212","article-title":"Vena caval filters for the prevention of pulmonary embolism","volume":"10","author":"Young","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtha.2025.11.021_bib65","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/jama.2015.3780","article-title":"Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial","volume":"313","author":"Mismetti","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2025.11.021_bib66","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/MEJ.0000000000000420","article-title":"Severe pulmonary embolism managed with high-flow nasal cannula oxygen therapy","volume":"24","author":"Messika","year":"2017","journal-title":"Eur J Emerg Med"},{"key":"10.1016\/j.jtha.2025.11.021_bib67","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.chest.2023.09.007","article-title":"Oxygen therapy in patients with intermediate-risk acute pulmonary embolism: a randomized trial","volume":"165","author":"Barrios","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2025.11.021_bib68","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-091567","article-title":"Supplemental oxygen for pulmonary embolism (SO-PE): study protocol for a mechanistic, randomised, blinded, cross-over study","volume":"14","author":"Lyhne","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.jtha.2025.11.021_bib69","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1056\/NEJMoa2509426","article-title":"Apixaban for extended treatment of provoked venous thromboembolism","volume":"393","author":"Piazza","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.11.021_bib70","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(24)02842-3","article-title":"Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial","volume":"405","author":"Couturaud","year":"2025","journal-title":"Lancet"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625009006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625009006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:01:53Z","timestamp":1781452913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625009006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1538783625009006"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.11.021","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of acute pulmonary embolism: a comparison of international guideline recommendations","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}